US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cardinal Health
(NY:
CAH
)
228.30
-1.79 (-0.78%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cardinal Health
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
These S&P500 stocks are gapping in today's session
↗
October 02, 2026
Via
Chartmill
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings?
September 29, 2026
Even though Cardinal Health (currently trading at $220.37 per share) has gained 6.8% over the last six months, it has lagged the S&P 500’s 22.1% return durin...
Via
StockStory
Topics
Economy
Stocks
Supply Chain
2 Large-Cap Stocks with Solid Fundamentals and 1 We Brush Off
September 23, 2026
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...
Via
StockStory
Topics
Economy
Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds
↗
September 19, 2026
Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what...
Via
MarketBeat
Topics
World Trade
Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand
↗
September 19, 2026
Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company’s fiscal 2026 performance was supported by double-digit earnings growth across each of its five operating segments, while fiscal 2027...
Via
MarketBeat
2 Cash-Producing Stocks Worth Your Attention and 1 We Ignore
September 14, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via
StockStory
Topics
Economy
Energy
2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down
August 25, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via
StockStory
Topics
Economy
Energy
Winners And Losers Of Q2: Cardinal Health (NYSE:CAH) Vs The Rest Of The Healthcare Providers & Services Stocks
August 23, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including Cardinal Health (NYSE:CAH) and it...
Via
StockStory
Topics
Economy
What to Know About the Latest Sale From Cardinal Health's Chief Accounting Officer
↗
August 23, 2026
Mary C. Scherer reduced her direct equity but retains 2,811 shares after the stock delivered a 58% return over the past year.
Via
The Motley Fool
Topics
Economy
Regulatory Compliance
Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know
↗
August 23, 2026
Alt divested part of his direct equity stake after the stock surged 57% over the past year, retaining 20,495 shares worth $4.82 million.
Via
The Motley Fool
Topics
Regulatory Compliance
Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know
↗
August 23, 2026
This insider sale cut an equity stake following a strong 57% one-year stock run, leaving $4.2 million in direct holdings.
Via
The Motley Fool
Topics
Regulatory Compliance
Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
↗
August 23, 2026
Weitzman's equity reduction follows a 57% one-year stock price surge, leaving her with $18.3 million in direct holdings.
Via
The Motley Fool
Topics
Regulatory Compliance
The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors
↗
August 23, 2026
Michelle Greene reduced her direct equity stake following strong stock appreciation, retaining 10,330 shares worth $2.43 million.
Via
The Motley Fool
Topics
Regulatory Compliance
Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know
↗
August 23, 2026
Jessica Mayer holds 33,076 shares valued at $7.77 million.
Via
The Motley Fool
Topics
Economy
Regulatory Compliance
Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know
↗
August 23, 2026
Hollar divested 125,000 shares across two trading sessions, reducing his direct holdings following a 58% one-year stock surge.
Via
The Motley Fool
Topics
Economy
Regulatory Compliance
Cardinal Health (CAH) Q4 2026 Earnings Call Transcript
↗
August 18, 2026
GLP-1 tailwinds and specialty strength drove pharma profit up 21% in Q4.
Via
The Motley Fool
Topics
Earnings
Economy
World Trade
5 Revealing Analyst Questions From Cardinal Health’s Q2 Earnings Call
August 18, 2026
Cardinal Health’s second quarter results reflected strong profit growth, despite revenue falling short of Wall Street’s expectations. Management credited bro...
Via
StockStory
Topics
Earnings
1 S&P 500 Stock Worth Investigating and 2 We Turn Down
August 13, 2026
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
Via
StockStory
Topics
Economy
Stocks
Cardinal Health Earnings: Can Perfection Get Priced In Twice?
↗
August 12, 2026
Cardinal Health stock hit a new all-time high after mixed earnings, with analyst price target hikes, gene therapy logistics wins and a 29-year dividend growth streak supporting the uptrend.
Via
MarketBeat
Topics
World Trade
CAH Q2 CY2026 Deep Dive: Specialty Momentum, Strategic Investments, and Guidance Above Street Expectations
August 12, 2026
Healthcare distributor and services company Cardinal Health (NYSE:CAH) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 5.8% year...
Via
StockStory
Topics
World Trade
Cardinal Health Q4 Earnings Call Highlights
↗
August 11, 2026
Cardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results marked by growth in revenue, operating earnings and adjusted earnings per share, supported by demand in its pharmaceutical and...
Via
MarketBeat
Topics
Earnings
World Trade
US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results
↗
August 11, 2026
US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal Health (NYSE: CAH) up 8%. Oil up 0.4%, gold up 0.6%.
Via
Benzinga
Topics
Stocks
Cardinal Health (NYSE:CAH) Misses Q2 CY2026 Sales Expectations
August 11, 2026
Healthcare distributor and services company Cardinal Health (NYSE:CAH) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 5.8% year...
Via
StockStory
Topics
Economy
Earnings To Watch: Cardinal Health (CAH) Reports Q2 Results Tomorrow
August 09, 2026
Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday before market hours. Here’s what to e...
Via
StockStory
McKesson's Compounding Keeps Adding Up
↗
July 31, 2026
McKesson posted strong fiscal 2026 results, raised guidance, boosted buybacks and its dividend, and maintains a Moderate Buy rating from analysts amid its evolving specialty business mix.
Via
MarketBeat
1 Surging Stock with Competitive Advantages and 2 Facing Headwinds
July 31, 2026
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...
Via
StockStory
Topics
Economy
Intellectual Property
1 Healthcare Stock to Keep an Eye On and 2 We Avoid
July 28, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
Via
StockStory
2 Unpopular Stocks That Deserve Some Love and 1 We Turn Down
July 22, 2026
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Via
StockStory
Topics
Economy
2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off
June 26, 2026
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it m...
Via
StockStory
Topics
Economy
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds
June 18, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Via
StockStory
Topics
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
